Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2019-03-01 2019-02-21
Drug Identification Number 02263866 02263866
Brand name ACT ETIDROCAL ACT ETIDROCAL
Common or Proper name ETIDROCAL ETIDROCAL
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ETIDRONATE DISODIUM CALCIUM ETIDRONATE DISODIUM CALCIUM
Strength(s) 400MG 500MG 400MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 90 90
ATC code M05BB M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-02-28 2019-02-28
Actual discontinuation date 2019-02-28 2019-02-28
Remaining supply date 2018-05-01 2018-05-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments